Stenger, Steffen

Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response

Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science

Immune Response and InflammationVitamin D Research Studies

Cited by 3,924

Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens

Tan, B. H., Meinken, C., Bastian, M., Bruns, H., Legaspi, A., Ochoa, M. T., Krutzik, S. R., Bloom, B. R., Ganz, T., Modlin, R. L., et al. (2006) · The Journal of Immunology

Tuberculosis Research and EpidemiologyAntimicrobial Peptides and Activities

Cited by 267

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

Nchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 146

Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages

Bruns, H., Stegelmann, F., Fabri, M., Döhner, K., van Zandbergen, G., Wagner, M., Skinner, M., Modlin, R. L., & Stenger, S. (2012) · The Journal of Immunology

Tuberculosis Research and EpidemiologyCellular transport and secretion

Cited by 112

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3

Tripathi, U., Nchioua, R., Prata, L. G. P. L., Zhu, Y., Gerdes, E. O. W., Giorgadze, N., Pirtskhalava, T., Parker, E., Xue, A., Espindola-Netto, J. M., et al. (2021) · Aging

Telomeres, Telomerase, and SenescenceSARS-CoV-2 and COVID-19 Research

Cited by 88

New Insights into the Interaction of Mycobacterium Tuberculosis and Human Macrophages

Bruns, H., & Stenger, S. (2014) · Future Microbiology

Tuberculosis Research and EpidemiologyImmune responses and vaccinations

Cited by 47

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes

Nchioua, R., Diofano, F., Noettger, S., von Maltitz, P., Stenger, S., Zech, F., Münch, J., Sparrer, K. M. J., Just, S., & Kirchhoff, F. (2022) · Signal Transduction and Targeted Therapy

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 35